The Latest Analyst Ratings for Pfizer
Portfolio Pulse from Benzinga Insights
Analysts have provided various ratings for Pfizer (NYSE:PFE) within the last quarter, with 1 bullish, 4 somewhat bullish, and 6 indifferent. The average price target is $51.18, implying an upside from the current price of $37.27. This average price target has increased by 5.07% over the past month.
July 21, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts' ratings for Pfizer indicate potential upside with an average price target of $51.18, up 5.07% over the past month.
The average price target given by analysts suggests a potential upside for Pfizer's stock. This, combined with the fact that the average price target has increased by 5.07% over the past month, indicates a positive short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100